Rapt Therapeutics Inc
(RAPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 1,528 | 1,277 | 935 | 0 | 0 |
| Gross Profit | 1,528 | 1,277 | 935 | N/A | N/A |
| Operating Expenses | 16,109 | 13,788 | 13,972 | 12,811 | 10,315 |
| Operating Income | -14,581 | -12,511 | -13,037 | -12,811 | -10,315 |
| Other Income | 237 | 391 | 135 | 259 | 344 |
| Pre-tax Income | -14,344 | -12,120 | -12,902 | -12,552 | -9,971 |
| Income Tax | 287 | 267 | 237 | N/A | N/A |
| Net Income Continuous | -14,631 | -12,387 | -13,139 | -13,212 | -9,971 |
| Net Income | $-14,631 | $-12,387 | $-13,139 | $-13,212 | $-9,971 |
| EPS Basic Total Ops | -4.80 | -4.08 | -4.48 | 244.64 | -99.28 |
| EPS Basic Continuous Ops | -4.79 | -4.07 | -4.52 | 244.64 | -99.31 |
| EPS Diluted Total Ops | -4.80 | -4.08 | -4.48 | 244.64 | -99.28 |
| EPS Diluted Continuous Ops | -4.79 | -4.07 | -4.52 | 244.64 | -99.31 |
| EBITDA(a) | $-14,101 | $-12,060 | $-12,842 | $-12,492 | $-9,973 |